Vor Biopharma Inc. (VOR) Institutional Ownership

Ownership Summary

Vor Biopharma Inc. (NASDAQ:VOR) has 34 institutional investors that have filed 13F reports for the period ending June 2025.

• These investors held 910.5% of outstanding shares in June 2025, down from 968.6% in March 2025.
• They decreased total shares held in Vor Biopharma by -3.46% from last quarter, and the number of investors in VOR decreased 52.78% annually.
• Of these 34 holders, 15 added to their stakes in Vor Biopharma, 10 trimmed positions, and 9 made no changes.
• Altogether, these fund groups held 57.03Mn shares in VOR by June 2025, down by 2.04Mn shares quarter on quarter, and up 2.01Mn shares year over year.
• TCG Crossover Management, LLC leads ownership in VOR with 5.67Mn shares as of June 30, 2025, equal to 90.57% of outstanding shares.
• Top purchasers of VOR stock for the quarter ending June 2025 included TCG Crossover Management, LLC (5.67Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn), MARSHALL WACE, LLP (1.15Mn), Venrock Adviser, LLC (1.1Mn), State Street Corp (1.03Mn).
• The largest sales of VOR for the quarter ending June 2025 came from FMR LLC (986.5K), Laurion Capital Management LP (315.82K), CITADEL ADVISORS LLC (285.13K), SPHERA FUNDS MANAGEMENT LTD. (88.5K), Johnson & Johnson (53.73K).
• Business Quant data shows the 10 biggest positions in Vor Biopharma as of June 2025 are held by TCG Crossover Management, LLC (5.67Mn), RA CAPITAL MANAGEMENT, L.P. (5.4Mn), FCPM III SERVICES B.V. (4.12Mn), Venrock Adviser, LLC (3.04Mn), Frazier Life Sciences Management, L.P. (2.54Mn), Caligan Partners LP (1.93Mn), Paradigm Biocapital Advisors LP (1.75Mn), GREAT POINT PARTNERS LLC (1.75Mn), FMR LLC (1.54Mn), VANGUARD CAPITAL MANAGEMENT LLC (1.43Mn).